China Pharmaceutical Supplier DengYueMed — A Guide to OTC, Prescription and Specialty Medicines

An overview of the OTC, prescription, biological, and specialty medicine categories offered by Chinese pharmaceutical suppliers, and DengYueMed's import, export, and cross-border supply chain services.

Top Stories

Latest Coverage

Ropeginterferon Alfa-2b, a Major Hematology Drug, Expands Its Indications: Essential Thrombocythemia
On October 15, 2026, the official website of China’s National Medical Products Administration (NMPA) indicated that r...
Understanding the Global Pharmaceutical Supply Chain: How Medicines Cross Markets and Borders
Access to medicines is an important issue in global healthcare. For patients, pharmacies, and healthcare institutions...
Zongertinib vs. Sevabertinib: Two Major Breakthroughs in HER2-Mutant Lung Cancer Treatment — What Are the Key Differences?
Beginning in 2025, zongertinib became the first oral targeted therapy approved worldwide for HER2-mutant NSCLC. Sevab...
From Intravenous Infusion to Oral Administration: Paclitaxel Oral Solution Gains a New Indication for Breast Cancer
In October 2026, a new development in the formulation of anticancer medicines emerged in China. On October 8, paclita...
KRAS Mutations and Precision Oncology: From KRAS G12C Inhibitors to Next-Generation RAS-Targeted Therapies
One of the key goals of precision oncology is to identify more targeted treatment strategies based on the molecular c...
Global First-in-Class Drug Approved in China: Vosoritide Brings Disease-Modifying Treatment to Children with Achondroplasia
On September 18, 2026, the official website of China’s National Medical Products Administration (NMPA) announced that...

In-Depth Analysis


This site uses Just the Docs, a documentation theme for Jekyll.